VEGF-D levels were higher in LAM than in non-LAM patients (1425 ± 872.1 pg/mL vs. 552 ± 276.5 pg/mL, <i>p</i> < 0.0001). This evidence concerns the gene VEGFD and lymphangioleiomyomatosis.